Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.
Role of Chlamydia in Multiple Sclerosis.
Natalizumab treatment for multiple sclerosis inducing a toxic acute myocardial damage. Is there any relationship?
Outer retinal changes following acute optic neuritis.
Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
Yield of training exchanges between Europe and Sub-Saharan Africa.
Regulation of myelination in the Central Nervous System by Nuclear Lamin B1 and non-coding RNAs.
[Coping with multiple sclerosis in partnerships : A systematic review of the literature.]
Multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort.
Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis.
Metabolic Control of Th17 Cell Generation and CNS Inflammation.
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes.
Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis.
A case of post-vaccination optic neuritis: coincidence or causative?
Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue.
The utility of the Six-Spot Step Test as a measure of walking performance in ambulatory individuals with Multiple Sclerosis across the disability spectrum.
Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients.
Social support, depression, and physical disability: Age and diagnostic group effects.
The clinical impact of cerebellar grey matter pathology in multiple sclerosis.
Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction.
Pain in multiple sclerosis: A systematic review of neuroimaging studies.
The Prevalence of Pain in Adults with Multiple Sclerosis: A Multicenter Cross-Sectional Survey.
Pages
« first
‹ previous
…
244
245
246
247
248
249
250
251
252
…
next ›
last »